The Antioxidant Action of Synthetic Oestrogens Involves Decreased Membrane Fluidity: Relevance to Their Potential Use as Anticancer and Cardioprotective Agents Compared to Tamoxifen?
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Free Radical Research
- Vol. 21 (3) , 187-194
- https://doi.org/10.3109/10715769409056569
Abstract
The synthetic oestrogens diethylstilboestrol, hexoestrol and 17 α-ethynyloestradiol are known to be good antioxidants, and we now report that they decrease membrane fluidity, in ox-brain phospholipid liposomes. The order of effectiveness was diethylstilboestrol > hexoestrol > 17 α-ethynyloestradiol and a good positive correlation was demonstrated between decreased membrane fluidity and antioxidant ability (measured as inhibition of liposomal lipid peroxidation: correlation coefficient, r = 0.99). This ability of diethylstilboestrol, hexoestrol and 17 α-ethynyloestradiol to decrease membrane fluidity is suggested, therefore, to be the mechanism of their antioxidant action. The membrane-modulating antioxidant action of these synthetic oestrogens is compared to that of tamoxifen and their potential use as anticancer and cardioprotective agents is discussed.Keywords
This publication has 29 references indexed in Scilit:
- Carcinogenic antioxidantsFEBS Letters, 1993
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- Breast cancer chemoprevention tamoxifen: Current issues and future prospectiveCancer, 1993
- Tamoxifen for the Primary Prevention of Breast Cancer: A Review and Critique of the Concept and TrialEpidemiologic Reviews, 1993
- Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.Journal of Clinical Oncology, 1993
- The case for clinical trials of tamoxifen for prevention of breast cancerThe Lancet, 1992
- The Treatment of Intracranial Malignant Gliomas Using Orally Administered Tamoxifen TherapyNeurosurgery, 1992
- The effect of adjuvant tamoxifen: The latest results from the Cancer Research Campaign adjuvant breast trialEuropean Journal Of Cancer, 1992
- Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinomaDigestive Diseases and Sciences, 1992
- Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer Reported at the Tenth Year of Follow-UpActa Oncologica, 1992